Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Pulmonary Arterial Hypertension.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT02958358
What this trial is testing

FDG Uptake and Lung Blood Flow in PAH Before and After Treatment With Ambrisentan

Who this might be right for
Pulmonary Arterial Hypertension
Robert Scott Harris, M.D.
Not applicableNo Longer AvailableNCT00878943
What this trial is testing

Open Label Access Study Of Sildenafil In Adult Patients With Pulmonary Arterial Hypertension Completing A1481244 Study

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Large-scale testing (Phase 3)Ended earlyNCT00811018
What this trial is testing

A Long-Term, Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Pfizer 1,192
Not applicableUnknownNCT00544726
What this trial is testing

Rehabilitation for Patients With Pulmonary Arterial Hypertension

Who this might be right for
Pulmonary Arterial Hypertension
Rabin Medical Center 45
Not applicableStudy completedNCT01607489
What this trial is testing

Non-invasive Diagnostics of Pulmonary Hypertension With Dual Energy Computed Tomography

Who this might be right for
Pulmonary Arterial Hypertension
Medical University of Graz 25
Not applicableLooking for participantsNCT04808596
What this trial is testing

Pulmonary Hypertension Biorepository and Registry

Who this might be right for
Pulmonary HypertensionPulmonary Arterial HypertensionPulmonary Hypertension Due to Left Heart Disease+6 more
University of Kansas Medical Center 300
Not applicableStudy completedNCT02825160
What this trial is testing

Non-interventional, Postauthorization Safety Study of Ventavis for Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Hypertension, Pulmonary
Bayer 282
Large-scale testing (Phase 3)Study completedNCT00325442
What this trial is testing

FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH)

Who this might be right for
Pulmonary Hypertension
United Therapeutics 354
Large-scale testing (Phase 3)Study completedNCT01934582
What this trial is testing

A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

Who this might be right for
Pulmonary Arterial Hypertension
United Therapeutics 13
Not applicableEnded earlyNCT00706082
What this trial is testing

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

Who this might be right for
Systemic SclerosisPulmonary Arterial HypertensionPulmonary Hypertension
Actelion 490
Post-approval studies (Phase 4)WithdrawnNCT01508780
What this trial is testing

Combined Use of Angiography, Optical Coherence Tomography and Intravascular Ultrasound in Evaluation of Pulmonary Vascular Structure and Function in Patients With Pulmonary Arterial Hypertension Treated With Oral Bosentan

Who this might be right for
Pulmonary Arterial Hypertension
Massachusetts General Hospital
Not applicableUnknownNCT03707561
What this trial is testing

RUS-registry of PH

Who this might be right for
Pulmonary Hypertension
Russian Cardiology Research and Production Center 200
Not applicableNot Yet RecruitingNCT07804537
What this trial is testing

Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Healthy Individuals

Who this might be right for
HealthyHealthy AdultHigh Altitude Effects+3 more
Silvia Ulrich Somaini 14
Not applicableEnded earlyNCT02246348
What this trial is testing

Evaluating Lung Doppler Signals in Patients With Systemic Sclerosis (SSc)

Who this might be right for
Systemic SclerosisPulmonary Hypertension
Echosense Ltd. 5
Not applicableStudy completedNCT00551408
What this trial is testing

Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension

Who this might be right for
Pulmonary Idiopathic Arterial Hypertension
Unidad de Investigacion Clinica en Medicina S.C. 20
Not applicableNot Yet RecruitingNCT07082933
What this trial is testing

Long-term Survival and Influencing Factors of Patients With Pulmonary Arterial Hypertension and Diabetes

Who this might be right for
Pulmonary Arterial Hypertension (PAH)
Xijing Hospital 5,000
Very early researchLooking for participantsNCT05452889
What this trial is testing

PET Image in PAH Patients

Who this might be right for
Pulmonary Arterial Hypertension
Stephen Y. Chan 71
Post-approval studies (Phase 4)Ended earlyNCT04955990
What this trial is testing

Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants

Who this might be right for
Pulmonary Arterial Hypertension
Actelion 232
Not applicableUnknownNCT05600218
What this trial is testing

RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists

Who this might be right for
Pulmonary Arterial Hypertension
Hospital Costa del Sol 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04175600
What this trial is testing

Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension

Who this might be right for
Hypertension, Pulmonary
Actelion 138
Next Page